Related Experiment Video
Updated: Aug 4, 2026

11:39
T Cells Capture Bacteria by Transinfection from Dendritic Cells
Published on: January 13, 2016
A novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA
L van de Corput1, P Chaux, E D van der Meijden
1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
Leukemia
|November 5, 2004
Summary
Researchers developed a novel bacterial cDNA library method to identify minor histocompatibility antigens. This approach aids in understanding T cell responses in stem cell transplantation for hematological malignancies.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Minor histocompatibility antigens (mHA) are crucial in stem cell transplantation, mediating graft rejection, graft-versus-host disease (GvHD), and graft-versus-leukemia (GvL) effects.
- Identifying mHA presented by HLA class II molecules is challenging, limiting our understanding of T cell-mediated responses.
Purpose of the Study:
- To develop an efficient strategy for identifying antigenic peptides processed via the HLA class II pathway.
- To facilitate the discovery of novel T cell targets in the context of stem cell transplantation.
Main Methods:
- Construction of a bacterial cDNA library to express proteins.
- Utilizing complement-opsonized bacteria for receptor-mediated uptake by Epstein-Barr virus-immortalized B cells (antigen-presenting cells).
- Screening the library with T cell clones specific for known HLA class II-restricted antigens (e.g., DBY).
Main Results:
- The bacterial library approach successfully identified HLA class II-restricted antigens, demonstrated by the isolation of DBY cDNAs.
- The method proved effective even when the target antigen was present at a low concentration (1 in 300 excess).
Conclusions:
- This strategy offers a rapid and efficient method for identifying HLA class II-restricted antigenic peptides.
- The approach has significant implications for understanding T cell recognition in transplantation immunology and developing targeted therapies.

